São Paulo, November, 2020. Eurofarma, a Brazilian multinational present in 20 countries, was voted Company of the Year, Americas in the seventh edition of the Global Generics & Biosimilars Awards, held by the Pharma Intelligence portal. The winners were announced at a digital ceremony on Tuesday, 3, which also celebrated the main achievements of the sector and companies working to make affordable medications available to more people around the world.
The Global Generics & Biosimilars Awards recognizes “best practices” in 14 categories in the Generic and Biosimilar industries, while encouraging improvements in all aspects of the way businesses are conducted. Each award effectively stresses the efforts made by these companies.
Eurofarma was also a finalist in the Corporate Social Responsibility (CSR) Initiative of the Year category, with its actions in response to the Covid-19 crisis and donations in humanitarian aid in Brazil. The Human Milk Bank – Lactare, which celebrated its first anniversary, was also among the finalist initiatives.
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
EUROFARMA ON SOCIAL MEDIA
www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarmalab | Twitter: @eurofarmaLab